Justice Department Reclassifies Specific Marijuana Products to Schedule III

The U.S. Department of Justice has reclassified certain marijuana products, specifically those approved by the FDA or regulated by state medical licenses, moving them to Schedule III. Concurrently, the Drug Enforcement Administration will initiate an expedited administrative hearing process. This process will consider a broader reclassification of marijuana from Schedule I to Schedule III, with the initial hearing set for late June 2026.